Clinical Trial Update: Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating photodynamic therapy for benign dermal neurofibromas in Neurofibromatosis Type 1. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Donald Basel | Conditions: NEUROFIBROMATOSIS 1 | Phase 2 | Status: RECRUITING